Arovella Therapeutics Ltd (ASX: ALA) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Arovella Therapeutics Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$60.44 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
1.21 billion
Earnings per share
-0.006
Dividend per share
N/A
Year To Date Return
-45.16%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Arovella Therapeutics Ltd (ASX: ALA)
Latest News
ASX Share Market News
Suda Pharmaceuticals share price soars 200% on TGA approval
ALA ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Arovella Therapeutics Ltd
Arovella Therapeutics Ltd. develops pharmaceuticals and distributes medical devices and consumables. Its activities include pharmaceutical development of drug delivery technology and medical devices and consumables distribution. The company operates through following business segment: Suda; and Malaria Research Company. The Suda segment includes research and development to create new human pharmaceutical products by combining proven drugs with innovated, patented, delivery technologies. The Malaria Research Company segment segment is the pharmaceutical development segment for the treatment of malaria. Arovella Therapeutics was founded on December 21, 1999 and is headquartered in Osborne Park, Australia.
ALA Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 20 Oct 2026 | $0.05 | $0.00 | 0.00% | 16,200 | $0.05 | $0.05 | $0.05 |
| 19 Oct 2026 | $0.05 | $0.00 | 0.00% | 538,136 | $0.05 | $0.05 | $0.05 |
| 16 Oct 2026 | $0.05 | $0.00 | 0.00% | 150,542 | $0.06 | $0.06 | $0.05 |
| 15 Oct 2026 | $0.05 | $0.00 | 0.00% | 1,732,288 | $0.05 | $0.05 | $0.05 |
| 14 Oct 2026 | $0.05 | $0.00 | 0.00% | 452,848 | $0.06 | $0.06 | $0.05 |
| 13 Oct 2026 | $0.06 | $0.00 | 0.00% | 2,511,630 | $0.06 | $0.06 | $0.05 |
| 12 Oct 2026 | $0.06 | $0.00 | 0.00% | 811,621 | $0.05 | $0.06 | $0.05 |
| 09 Oct 2026 | $0.05 | $0.00 | 0.00% | 1,142,156 | $0.05 | $0.05 | $0.05 |
| 08 Oct 2026 | $0.05 | $0.00 | 0.00% | 594,971 | $0.05 | $0.05 | $0.05 |
| 07 Oct 2026 | $0.05 | $0.00 | 0.00% | 485,494 | $0.05 | $0.05 | $0.05 |
| 06 Oct 2026 | $0.05 | $0.00 | 0.00% | 282,049 | $0.05 | $0.05 | $0.05 |
| 05 Oct 2026 | $0.05 | $0.00 | 0.00% | 109,367 | $0.05 | $0.05 | $0.05 |
| 02 Oct 2026 | $0.05 | $0.00 | 0.00% | 401,127 | $0.05 | $0.05 | $0.05 |
| 01 Oct 2026 | $0.05 | $0.00 | 0.00% | 683,542 | $0.05 | $0.05 | $0.05 |
| 30 Sep 2026 | $0.05 | $0.00 | 0.00% | 2,844,650 | $0.05 | $0.05 | $0.05 |
| 29 Sep 2026 | $0.05 | $0.00 | 0.00% | 846,555 | $0.05 | $0.05 | $0.05 |
| 28 Sep 2026 | $0.05 | $0.00 | 0.00% | 2,750,238 | $0.05 | $0.05 | $0.05 |
| 25 Sep 2026 | $0.05 | $0.00 | 0.00% | 1,089,420 | $0.05 | $0.05 | $0.05 |
| 24 Sep 2026 | $0.05 | $0.00 | 0.00% | 656,665 | $0.06 | $0.06 | $0.05 |
| 23 Sep 2026 | $0.06 | $0.00 | 0.00% | 314,076 | $0.06 | $0.06 | $0.06 |
| 22 Sep 2026 | $0.06 | $0.00 | 0.00% | 224,036 | $0.06 | $0.06 | $0.06 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 09 Jun 2026 | David Williams | Buy | 200,000 | $13,400 |
On-market trade.
|
| 24 Nov 2025 | Elizabeth Stoner | Expiry | 1,242,353 | $103,115 |
Options expired.
|
| 24 Nov 2025 | Elizabeth Stoner | Buy | 1,157,647 | $96,084 |
Exercise of options.
|
| 24 Nov 2025 | Elizabeth Stoner | Exercise | 1,157,647 | $96,084 |
Exercise of options.
|
| 12 Nov 2025 | Debora Barton | Exercise | 1,013,333 | $52,693 |
Exercise of options.
|
| 12 Nov 2025 | Debora Barton | Expiry | 1,386,667 | $133,120 |
Options expired.
|
| 12 Nov 2025 | Debora Barton | Buy | 1,013,333 | $97,279 |
Exercise of options.
|
| 10 Nov 2025 | Gary Phillips | Issued | 1,160,000 | $103,240 |
Issue of options.
|
| 10 Nov 2025 | Michael Baker | Issued | 1,831,266 | $162,982 |
Issue of options.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David John Williams | Non-Executive DirectorNon-Executive Chairman | Apr 2026 |
Mr Williams has expertise in business development, mergers and acquisitions (M&A), and capital markets.
|
| Mr Mark P Diamond | Non-Executive Director | Apr 2026 |
Mr Diamond is an experienced senior executive, who previously served as CEO of Antisense Therapeutics. Mr Diamond has a track record in funding, licencing deals, and partnerships. He is currently Biotech Advisor to Spark Plus and Locust Walk, and his global C-Suite executive leadership experience spans healthcare strategy, compliance and risk management, financial management, and board governance.
|
| Dr Michael S Perry | Non-Executive Director | Apr 2026 |
--
|
| Dr Michael Joseph Thurn | Non-Executive Director | Apr 2026 |
Mr Thurn has more than 25 years'experience across drug discovery, preclinical and clinical development, regulation, commercialisation, capital raising and corporate leadership.
|
| Dr Nicole Louise van der Weerden | Acting Chief Executive Officer | May 2026 |
-
|
| Mr Lachie Mallia | Chief Financial OfficerCompany Secretary | Jan 2026 |
-
|
| Nicole Louise van der Weerden | Acting Chief Executive Officer |
-
|
|
| Lachie Mallia | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Biotech Capital Management | 129,606,597 | 10.72% |
| Richard John Mann | 68,487,674 | 5.67% |
| Netwealth Investments Limited-Wrap Services A/C | 33,595,541 | 2.78% |
| Netwealth Investments Limited-Super Services A/C | 32,619,851 | 2.70% |
| Ajava Holdings Pty Ltd | 30,000,000 | 2.48% |
| UBS Nominees Pty Ltd | 29,070,196 | 2.40% |
| Blackburne Capital Pty Ltd | 27,268,039 | 2.26% |
| Legacy Asset Holdings Pty Ltd | 22,362,889 | 1.85% |
| Dylide Pty Ltd | 16,227,481 | 1.34% |
| M & M Stock One Pty Ltd-The M & M Stock One A/C | 15,958,668 | 1.32% |
| Mr James Evan Hughes-Morris | 15,057,777 | 1.25% |
| Morgan Stanley Australia Securities (Nominee) Pty Limited-No 1 Account | 12,043,779 | 1.00% |
| Moovnup Pty Ltd-Moovnup A/C | 11,593,075 | 0.96% |
| Mr Neil Donald Delroy-Ndd Investment A/C | 11,467,159 | 0.95% |
| Widerange Corporation Pty Ltd | 10,767,789 | 0.89% |
| Mr Brendan John Martin & Mrs Sharon Ann Martin-Jaknic Super A/C | 9,564,970 | 0.79% |
| Mr Marvin Weng Chung Leong & Mrs Tien Ju Yeap-Marju Super A/C | 9,473,666 | 0.78% |
| Mr Murray James Hull & Mrs Nicola Jane Hull-Murnic Family A/C | 9,287,206 | 0.77% |
| Mr Paul Ramsay & Mrs Terrel Jean Ramsay-P & T Ramsay Super A/C | 7,928,338 | 0.66% |
| Mr Jason Gibbons & Mrs Koby Gibbons-Gibbons Family A/C | 7,863,041 | 0.65% |
